The LEO Foundation Award 2019 – Region EMEA
Grantee: Dr. Shoba Amarnath
Amount: USD 100,000
Grant category: LEO Foundation Awards
Year: 2019
Geography: United Kingdom
Shoba Amarnath is a Research Fellow at the Institute of Cellular Medicine at Newcastle University, UK
She receives 100,000 USD for her research in the field of immune tolerance in cutaneous inflammation.
Mechanisms involved in decreased cutaneous immunity during ageing: reversal by Vitamin D pre-treatment
Grantee: Arne Akbar, Professor of Immunology, University College London
Amount: DKK 4,478,517
Grant category: Research Grants in open competition
Year: 2019
Geography: United Kingdom
There is a sterile inflammatory response to needle challenge driven by recruitment of inflammatory monocytes to the skin in old humans. This inflammatory response negatively correlates with cutaneous immunity after injection of varicella zoster virus antigens into the skin. Inhibition of the inflammation associated with the injury response, with a p38-MAPkinase inhibitor, reduced inflammatory monocyte recruitment and significantly enhanced antigen-specific immunity.
The aim of this project is to understand how inflammation and inflammatory monocytes inhibit antigen-specific T cells in the skin of old human volunteers.
The following experimental questions will be addressed: 1) Which cells are responsible for the inflammatory response to needle injury and how does the interaction between the infiltrating monocytes and other inflammatory populations amplify the response? 2) How are the inflammatory monocytes recruited to the site of challenge in the skin? 3) How do the recruited monocytes inhibit antigen-specific immunity in vivo in the old? 4) Using biobanked skin biopsy samples before and after the same older subjects have been treated with Vitamin D, we will determine gene expression signatures of how this treatment enhances cutaneous antigen-specific immunity.
These investigations will identify ways to enhance the immunity of older humans to vaccination and also infection and malignancy.
Establishing the keratinocyte stem cell basis for skin field cancerisation and squamous cell carcinoma
Grantee: Girish Patel, Honorary Senior Lecturer, Cardiff University
Amount: DKK 3,935,737
Grant category: Research Grants in open competition
Year: 2019
Geography: United Kingdom
Epithelial tissues, the environmental barriers of our bodies, are constantly exposed to cancer causing agents. As such carcinoma, the cancer of epithelial tissues, are the most common form of cancer accounting for 85% of all cancers and 78% of all cancer associated deaths.
Many carcinomas arise from a pre-cancerous transformation, known as intraepithelial neoplasia or field cancerisation (FC), within which multiple carcinoma can develop.
By studying skin FC in a mouse model of human papillomavirus 8 infection (K14-HPV8-CER), we have uncovered specific expansion of only the Lrig1 hair follicle junctional zone keratinocyte stem cells (HFJZKSC) driven by ΔNp63 expression, which is the basis for skin FC 1-3.
These findings raised two important fundamental questions:
- How does HPV8 induce Lrig1 KSC expansion? The background for this proposal and ongoing work (Leo Foundation grant 2017, LF17070).
- Are Lrig1 derived cells responsible for squamous cell carcinoma (SCC)? The basis for this Leo grant proposal.
The current Leo Foundation grant allowed us to identify E6 as the HPV8 protein responsible for Lrig1 KSC expansion through activation of the STAT3 intracellular signalling pathway.
Therefore, we are now positioned for a follow-on grant to determine whether Lrig1 derived cells are responsible for FC associated SCC. Herein we aim to:
1) confirm that Lrig1 HFJZKSC proliferation is responsible KSC expansion into the infundibulum and adjoining interfollicular epidermis
2) test the hypothesis that Lrig1 HFJZKSC progeny give rise to papilloma and SCC
3) determine whether STAT3 mediate HFJZKSC expansion occurs in human skin FC.